Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial
Open Access
- 18 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (6) , 3416
Abstract
In arterial hypertension, the dysregulation of several metabolic pathways is closely associated with chronic immune imbalance and inflammation progression. With time, these disturbances lead to the development of progressive disease and end-organ involvement. However, the influence of cholecalciferol on metabolic pathways as a possible mechanism of its immunomodulatory activity in obesity-related hypertension is not known. In a phase 2, randomized, single-center, 24-week trial, we evaluated, as a secondary outcome, the serum metabolome of 36 age- and gender-matched adults with obesity-related hypertension and vitamin D deficiency, before and after supplementation with cholecalciferol therapy along with routine medication. The defined endpoint was the assessment of circulating metabolites using a nuclear magnetic resonance-based metabolomics approach. Univariate and multivariate analyses were used to evaluate the systemic metabolic alterations caused by cholecalciferol. In comparison with normotensive controls, hypertensive patients presented overall decreased expression of several amino acids (p < 0.05), including amino acids with ketogenic and glucogenic properties as well as aromatic amino acids. Following cholecalciferol supplementation, increases were observed in glutamine (p < 0.001) and histidine levels (p < 0.05), with several other amino acids remaining unaffected. Glucose (p < 0.05) and acetate (p < 0.05) decreased after 24 weeks in the group taking the supplement, and changes in the saturation of fatty acids (p < 0.05) were also observed, suggesting a role of liposoluble vitamin D in lipid metabolism. Long-term cholecalciferol supplementation in chronically obese and overweight hypertensives induced changes in the blood serum metabolome, which reflected systemic metabolism and may have fostered a new microenvironment for cell proliferation and biology. Of note, the increased availability of glutamine may be relevant for the proliferation of different T-cell subsets.Keywords
Funding Information
- Núcleo de Estudos de Hipertensão da Beira Interior (001-15, REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012)
- Italfarmaco (001-15, REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012)
- FEDER (European Regional Development Fund) (001-15, REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012)
- FCT (Fundação para a Ciência e a Tecnologia or Portuguese Foundation for Science and Technology) (001-15, REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012)
- Rede Nacional de Ressonância Magnética Nuclear (RNRMN) (001-15, REEQ/481/QUI/2006, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012)
This publication has 55 references indexed in Scilit:
- RETRACTED: Calcitriol suppresses gastric cancer progression and cisplatin resistance by inhibiting glycolysis and M2 macrophage polarization through inhibition of mTOR activationEnvironmental Toxicology, 2023
- In obese hypertensives cholecalciferol inhibits circulating TH17 cells but not macrophage infiltration on adipose tissueClinical Immunology, 2023
- Metabolomic basis for response to high dose vitamin D in critical illnessClinical Nutrition, 2020
- Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data AnalysisCurrent Protocols in Bioinformatics, 2019
- Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone StrengthJAMA, 2019
- BCAA Metabolism and Insulin Sensitivity – Dysregulated by Metabolic Status?Molecular Nutrition & Food Research, 2018
- Fatty Acid Oxidation in Zebrafish Adipose Tissue Is Promoted by 1α,25(OH)2D3Cell Reports, 2017
- mTOR Signaling in Growth, Metabolism, and DiseaseCell, 2017
- In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathwayEndocrine, 2016
- Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndromeMolecular Nutrition & Food Research, 2011